Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MURGY | CI |
|---|---|---|
| Price | $11.45 | $271.29 |
| Change today | ▲ 0.18% | ▲ 0.28% |
| Market cap | $71.65B | $71.69B |
| Return, 3 months | -1.2% | -4.8% |
| Return, year to date | -9.2% | +0.2% |
| Return, 1 year | -10.1% | -8.4% |
| P/E (TTM) | 9.2 | 11.2 |
| P/B | 1.8 | 1.7 |
| P/E percentile vs own 5y | – | 12th |
| Dividend yield | 4.91% | 2.26% |
| Revenue growth (YoY, latest qtr) | – | +6.7% |
| Net profit growth (YoY) | – | +14.9% |
| Gross margin | – | 8.8% |
| Operating margin | – | 3.2% |
| Net margin | – | 2.3% |
| Return on equity | – | 15.5% |
| Analyst target vs. price | – | +24.5% |
| Analyst buy share | – | 71% |
| RSI (14) | 44 | 45 |
| 30-day volatility | 22.0% | 22.5% |
| Max drawdown, 1 year | -21.0% | -21.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
